NCT01657266View on ClinicalTrials.gov

Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
CataractPhacoemulsification Cataract Surgery
Interventions
DRUG

PRO-155

Pre-medication (before surgery) and maintenance treatment.

DRUG

Nevanac

Pre-medication (before surgery) and maintenance treatment.

Trial Locations (1)

44280

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT01657266 - Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification | Biotech Hunter | Biotech Hunter